Quinoline derivatives as ligands for the neuropeptide Y receptor

Details for Australian Patent Application No. 2002338896 (hide)

Owner F.Hoffman-La Roche AG

Inventors Plancher, Jean-Marc; Mueller, Werner; Pflieger, Philippe; Neidhart, Werner

Agent Spruson & Ferguson

Pub. Number AU-B-2002338896

PCT Number PCT/EP02/05120

PCT Pub. Number WO2002/094789

Priority 01112370.0 21.05.01 EP

Filing date 8 May 2002

Wipo publication date 3 December 2002

Acceptance publication date 27 April 2006

International Classifications

C07D 215/42 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/4706 (2006.01) - 4-Aminoquinolines

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 19/02 (2006.01) Drugs for skeletal disorders

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 491/10 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 01112370.0 21.05.01 EP

8 May 2003 Application Open to Public Inspection

  Published as AU-B-2002338896

27 April 2006 Application Accepted

  Published as AU-B-2002338896

24 August 2006 Standard Patent Sealed

4 December 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002338897-Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt

2002338895-2' - METHYL5-(1,3,4-OXADIAZOL-2-YL)-1,1'-BIPHE NYL-4-CARBOXAMIDE DERIVATIVES AND THEIR USE AS P38 KINASE INHIBITORS